Work

Abstract P1-15-14: Neoadjuvant liposomal doxorubicin and carboplatin is effective and tolerable for the treatment of triple negative breast cancer

Year: 2019

Type: conference-abstract

Source: Cancer Research

DOI: 10.1158/1538-7445.sabcs18-p1-15-14

Authors: N Chan, GM Riedlinger, S-e Lu, KT Pham, LJ Kirstein, FG Eladoumikdachi, MA George, LB Potdevin, MJ Kowzun, SA Desai, DM Tang, CO Omene, ST Wong, L Rodriguez-Rust, S Kumar, TJ Kearney, C Liu, S Ganesan, DL Toppmeyer, KM Hirshfield

Institutions: Rutgers, The State University of New Jersey, Rutgers Health, Rutgers Cancer Institute, Rutgers New Jersey Medical School

Language: English

Topic: Breast Cancer Treatment Studies

Subfield: Cancer Research

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2943914303

Cites:

Cited by: 2

Related to: 10